The BimSR implant was established to target drug delivery directly to the iris and ciliary system, thereby altering matrix metalloprotein generation and lessening extracellular matrix in outflow tissues[sixty five]–[66]. By upregulating this pathway, drug distribution is restricted to the applicable tissue targets Consequently lowering the incide